The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Effects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients
Open accessAbstract
Besides being part of anti- Helicobacter pylori treatment regimens, proton pump inhibitors (PPIs) are increasingly being used to treat dyspepsia. However, little is known about the effects of PPIs on the human gastric microbiota, especially those related to H. pylori infection. The goal of this study was to characterize the stomach microbial communities in patients with dyspepsia and to investigate their relationships with PPI use and H. pylori status. Using 16S rRNA gene pyrosequencing, we analyzed the mucosa-associated microbial populations of 24 patients, of whom 12 were treated with the PPI omeprazole and 9 (5 treated and 4 untreated) were positive for H. pylori infection. The Proteobacteria , Firmicutes , Bacteroidetes , Fusobacteria , and Actinobacteria phyla accounted for 98% of all of the sequences, with Helicobacter , Streptococcus , and Prevotella ranking among the 10 most abundant genera. H. pylori infection or PPI treatment did not significantly influence gastric microbial species composition in dyspeptic patients. Principal-coordinate analysis of weighted UniFrac distances in these communities revealed clear but significant separation according to H. pylori status only. However, in PPI-treated patients, Firmicutes , particularly Streptococcaceae , were significantly increased in relative abundance compared to those in untreated patients. Consistently, Streptococcus was also found to significantly increase in relation to PPI treatment, and this increase seemed to occur independently of H. pylori infection. Our results suggest that Streptococcus may be a key indicator of PPI-induced gastric microbial composition changes in dyspeptic patients. Whether the gastric microbiota alteration contributes to dyspepsia needs further investigation. IMPORTANCE Although PPIs have become a popular treatment choice, a growing number of dyspeptic patients may be treated unnecessarily. We found that patients treated with omeprazole showed gastric microbial communities that were different from those of untreated patients. These differences regarded the abundances of specific taxa. By understanding the relationships between PPIs and members of the gastric microbiota, it will be possible to envisage new strategies for better managing patients with dyspepsia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The primary abundance of Streptococcaceae was also demonstrated in dyspeptic patients during PPI treatment, suggesting that this ecological switch in favor of Streptococcaceae could be an independent indicator of gastric dysbiosis due to these drugs[59].”
From Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified (2019) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Search and clustering orders of magnitude faster than BLAST
Edgar, R. C. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq461 · Cited by 21,098
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
UCHIME improves sensitivity and speed of chimera detection
Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C., & Knight, R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr381 · Cited by 15,114
FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments
Price, M. N., Dehal, P. S., & Arkin, A. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009490 · Cited by 14,894
PyNAST: a flexible tool for aligning sequences to a template alignment
Caporaso, J. G., Bittinger, K. L., Bushman, F. D., DeSantis, T. Z., Andersen, G. L., & Knight, R. D. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp636 · Cited by 3,449
THE POPULATION FREQUENCIES OF SPECIES AND THE ESTIMATION OF POPULATION PARAMETERS
Good, I. J. (1953) · Biometrika · doi:10.1093/biomet/40.3-4.237 · Cited by 3,427
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
Malfertheiner, P., Mégraud, F., O'Morain, C. A., Atherton, J. C., Axon, A. T. R., Bazzoli, F., Gensini, G. F., Gisbert, J. P., Graham, D. Y., Rokkas, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2012-302084 · Cited by 2,346
Statistical Methods for Detecting Differentially Abundant Features in Clinical Metagenomic Samples
White, J. R., Nagarajan, N., & Pop, M. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000352 · Cited by 1,599
UniFrac – An online tool for comparing microbial community diversity in a phylogenetic context
Lozupone, C., Hamady, M., & Knight, R. D. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-371 · Cited by 1,454
Cited by
Sorted by citations
Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified
Bruno, G., Zaccari, P., Rocco, G., Scalese, G., Panetta, C., Porowska, B., Pontone, S., & Severi, C. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i22.2706 · Cited by 258
Novel concepts in the pathophysiology and treatment of functional dyspepsia
Wauters, L. I., Talley, N. J., Walker, M. M., Tack, J. F., & Vanuytsel, T. (2019) · Gut · doi:10.1136/gutjnl-2019-318536 · Cited by 231
Gut microbiota composition is associated with polypharmacy in elderly hospitalized patients
Ticinesi, A., Milani, C., Lauretani, F., Nouvenne, A., Mancabelli, L., Lugli, G. A., Turroni, F., Duranti, S., Mangifesta, M., Viappiani, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10734-y · Cited by 211
Parsons, B. N., Ijaz, U. Z., D’Amore, R., Burkitt, M. D., Eccles, R., Lenzi, L., Duckworth, C. A., Moore, A. R., Tiszlavicz, L., Varro, A., et al. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006653 · Cited by 210
British Society of Gastroenterology guidelines on the management of functional dyspepsia
Black, C. J., Paine, P., Agrawal, A., Aziz, I., Eugenicos, M. P., Houghton, L. A., Hungin, P., Overshott, R., Vasant, D. H., Rudd, S., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327737 · Cited by 216
Systematic review: gastric microbiota in health and disease
Rajilić-Stojanović, M. D., Figueiredo, C., Smet, A., Hansen, R., Kupčinskas, J., Rokkas, T., Andersen, L. P., Machado, J. C., Ianiro, G., Gasbarrini, A., et al. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15650 · Cited by 176
Self-citationWang, Z., Gao, X., Zeng, R., Wu, Q., Sun, H., Wu, W., Zhang, X., Sun, G., Yan, B., Wu, L., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00997 · Cited by 137
Quaranta, G., Sanguinetti, M., & Masucci, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02653 · Cited by 131
Self-citationThe Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors
Minalyan, A., Gabrielyan, L., Scott, D. R., Jacobs, J. P., & Pisegna, J. R. (2017) · Current Gastroenterology Reports · doi:10.1007/s11894-017-0577-6 · Cited by 134
Macke, L., Schulz, C., Koletzko, L., & Malfertheiner, P. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15604 · Cited by 118
Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use
Naito, Y., Kashiwagi, K., Takagi, T., Andoh, A., & Inoüe, R. (2018) · Digestion · doi:10.1159/000481813 · Cited by 109
The Human Gastric Microbiome Is Predicated upon Infection with Helicobacter pylori
Klymiuk, I., Bilgilier, C., Stadlmann, A., Thannesberger, J., Kastner, M.-T., Högenauer, C., Püspök, A., Biowski-Frotz, S., Schrutka-Kölbl, C., Thallinger, G., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02508 · Cited by 108
Shi, Y., Cai, S., Tian, Y.-P., Zhao, H., Zhang, Y.-B., Chen, J., Ren, R.-R., Luo, X., Peng, L., Sun, G., et al. (2019) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2018.12.004 · Cited by 83
Gastric Adenocarcinoma of the Fundic Gland Type
Benedict, M., Lauwers, G. Y., & Jain, D. (2018) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqy019 · Cited by 76
Gut Microbiota Dysbiosis in Functional Dyspepsia
Tziatzios, G., Gkolfakis, P., Papanikolaou, I. S., Mathur, R., Pimentel, M., Giamarellos‐Bourboulis, E. J., & Τriantafyllou, Κ. (2020) · Microorganisms · doi:10.3390/microorganisms8050691 · Cited by 78
Wizenty, J., & Sigal, M. J. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01042-2 · Cited by 86
Fecal Microbiota Transplantation and Other Gut Microbiota Manipulation Strategies
Quaranta, G., Guarnaccia, A., Fancello, G., Agrillo, C., Iannarelli, F., Sanguinetti, M., & Masucci, L. (2022) · Microorganisms · doi:10.3390/microorganisms10122424 · Cited by 72
Self-citationHelicobacter pylori Infection, the Gastric Microbiome and Gastric Cancer
Pereira‐Marques, J., Ferreira, R. M., Pinto-Ribeiro, I., & Figueiredo, C. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2019_366 · Cited by 77
Microbiota in the stomach and application of probiotics to gastroduodenal diseases
Koga, Y. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i47.6702 · Cited by 67
Plomer, M., Perez, M. I., & Greifenberg, D. M. (2020) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00333-2 · Cited by 56
Ciucci, S., Ge, Y., Durán, C., Palladini, A., Jiménez-Jiménez, V., Martínez-Sánchez, L. M., Wang, Y., Sales, S., Shevchenko, A., Poser, S., et al. (2017) · Scientific Reports · doi:10.1038/srep43946 · Cited by 55
Self-citationOvergrowth of Lactobacillus in gastric cancer
Li, Z., Liu, J.-X., Lu, L., Wang, L., Xu, L., Guo, Z.-H., & Dong, Q. (2021) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v13.i9.1099 · Cited by 51
Helicobacter pylori, gastric microbiota and gastric cancer relationship: Unrolling the tangle
Liatsos, C. N., Papaefthymiou, A., Kyriakos, N., Galanopoulos, M., Doulberis, M., Giakoumis, M., Petridou, E., Mavrogiannis, C. C., Rokkas, T., & Kountouras, J. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i5.959 · Cited by 52
The relationship between gastric microbiota and gastric disease
Zhang, S., Shi, D., Li, M., Li, Y., Wang, X., & Li, W. (2019) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2019.1591499 · Cited by 51
Duodenal Dysbiosis and Relation to the Efficacy of Proton Pump Inhibitors in Functional Dyspepsia
Wauters, L. I., Tito, R. Y., Ceulemans, M., Lambaerts, M., Accarie, A., Rymenans, L., Verspecht, C., Tóth, J. G., Mols, R., Augustijns, P., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413609 · Cited by 46
Lin, M., Chai, W., Ou-Yang, C., Huang, Q., Xu, X., & Peng, Y. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.05.172 · Cited by 44
Microbiome in Critical Care: An Unconventional and Unknown Ally
Zanza, C., Romenskaya, T., Thangathurai, D., Ojetti, V., Saviano, A., Abenavoli, L., Robba, C., Cammarota, G., Franceschi, F., Piccioni, A., et al. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210915115056 · Cited by 43
Self-citationBarra, W. F., Sarquis, D. P., Khayat, A. S., Khayat, B. C. M., Demachki, S., Anaissi, A. K. M., Ishak, G., dos Santos, N. P. C., dos Santos, S. E. B., Burbano, R. M. R., et al. (2021) · Pathobiology · doi:10.1159/000512833 · Cited by 42
Durán, C., Ciucci, S., Palladini, A., Ijaz, U. Z., Zippo, A. G., Sterbini, F. P., Masucci, L., Cammarota, G., Ianiro, G., Spuul, P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22135-x · Cited by 43
Self-citationGastric microbiota dysbiosis and Helicobacter pylori infection
Zhang, L., Zhao, M. X., & Fu, X. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1153269 · Cited by 43
Chen, B., Chen, Y., Dragomir, M. P., Chi, D., Chen, W., Horst, D. A., Călin, G. A., & Li, Q. (2022) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359221111703 · Cited by 38
Posteraro, B., Sterbini, F. P., Petito, V., Rocca, S., Cubeddu, T., Graziani, C., Arena, V., Vassallo, G. A., Mosoni, C., Lopetuso, L. R., et al. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13900 · Cited by 37
Self-citationProton Pump Inhibitors and Oral–Gut Microbiota: From Mechanism to Clinical Significance
Zhang, X., Li, Q., Xia, S., He, Y., Liu, Y., Yang, J., & Xiao, X. (2024) · Biomedicines · doi:10.3390/biomedicines12102271 · Cited by 37
Seoane, M., Esperanza, M., & Cid, Á. (2017) · Aquatic Toxicology · doi:10.1016/j.aquatox.2017.08.001 · Cited by 35
Šegregur, D., Flanagan, T. R., Mann, J., Moir, A. J., Karlsson, Ε., Hoch, M., Carlile, D. J., Sayah‐Jeanne, S., & Dressman, J. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.06.021 · Cited by 34
Wang, Y., Jia, Y., Liu, X., Yang, K., Lin, Y., Shao, Q., & Ling, J. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117659 · Cited by 32
Mucosa-Associated Microbiota in the Gastrointestinal Tract of Healthy Japanese Subjects
Kashiwagi, S., Naito, Y., Inoüe, R., Takagi, T., Nakano, T., Inada, Y., Fukui, A., Katada, K., Mizushima, K., Kamada, K., et al. (2019) · Digestion · doi:10.1159/000496102 · Cited by 31
Gastric Microbiota beyond H. pylori: An Emerging Critical Character in Gastric Carcinogenesis
Wen, J., Lau, H. C.-H., Peppelenbosch, M. P., & Yu, J. Q. (2021) · Biomedicines · doi:10.3390/biomedicines9111680 · Cited by 32
Proton Pump Inhibitors, H2 Blocker Use, and Risk of Inflammatory Bowel Disease in Children
Schwartz, N. R. M., Hutfless, S. M., Herrinton, L. J., Amsden, L. B., Fevrier, H. B., Giefer, M. J., Lee, D. Y., Suskind, D. L., Delaney, J. A., & Phipps, A. I. (2019) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-24.6.489 · Cited by 30
Impact of Helicobacter pylori eradication on the gastric microbiome
Mao, L.-Q., Zhou, Y., Wang, S., Chen, L., Hu, Y., Yu, L.-M., Xu, J., & Lü, B. (2021) · Gut Pathogens · doi:10.1186/s13099-021-00460-2 · Cited by 31
Mandarino, F. V., Sinagra, E., Barchi, A., Verga, M. C., Brinch, D., Raimondo, D., & Danese, S. (2023) · Microorganisms · doi:10.3390/microorganisms11051122 · Cited by 29
The role of gastric microecological dysbiosis in gastric carcinogenesis
Huang, H., Zhong, W., Wang, X., Yang, Y. Z., Wu, T., Chen, R., Liu, Y., He, F., & Li, . (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1218395 · Cited by 31
The Potential Role of Hypochlorhydria in the Development of Duodenal Dysbiosis: A Preliminary Report
Filardo, S., Scalese, G., Virili, C., Pontone, S., Pietro, M. D., Covelli, A., Bedetti, G., Marinelli, P., Bruno, G., Stramazzo, I., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.854904 · Cited by 25
Zhou, C., Bisseling, T. M., van der Post, R. S., & Boleij, A. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.11.053 · Cited by 26
Cervantes, J., Michael, M., Hong, B.-Y., Springer, A., Guo, H., Mendoza, B., Zeng, M., Sundin, O. H., & McCallum, R. W. (2021) · Journal of Investigative Medicine · doi:10.1136/jim-2020-001642 · Cited by 25
Other Helicobacters, gastric and gut microbiota
Péré‐Védrenne, C., Flahou, B., Loke, M. F., Ménard, A., & Vadivelu, J. (2017) · Helicobacter · doi:10.1111/hel.12407 · Cited by 24
Gastric Microbiota: Tracing the Culprit
Petra, C. V., Rus, A., & Dumitrascu, D. L. (2017) · Medicine and Pharmacy Reports · doi:10.15386/cjmed-854 · Cited by 23
Lee, K. J. (2021) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm21042 · Cited by 22
Microbiome: what intensivists should know
Nakov, R., Segal, J. P., Settanni, C. R., Bibbò, S., Gasbarrini, A., Cammarota, G., & Ianiro, G. (2020) · Minerva Anestesiologica · doi:10.23736/s0375-9393.20.14278-0 · Cited by 21
Self-citationDiversification and deleterious role of microbiome in gastric cancer
Chattopadhyay, I., Gundamaraju, R., & Rajeev, A. (2023) · Cancer Reports · doi:10.1002/cnr2.1878 · Cited by 20
Considering gut microbiota disturbance in the management of Helicobacter pylori infection
Lopetuso, L. R., Napoli, M., Rizzatti, G., Scaldaferri, F., Franceschi, F., & Gasbarrini, A. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1503946 · Cited by 21
Self-citationDuodenal microbiome in patients with or without Helicobacter pylori infection
Suárez‐Jaramillo, A., Baldeon, M. E., Prado, B., Fornasini, M., Cohen, H., Flores, N., Salvador, I., Cargua, O., Realpe, J. L., & Cárdenas, P. (2020) · Helicobacter · doi:10.1111/hel.12753 · Cited by 20
Wu, J., Zhou, X., Dou, Z., Wu, T., Liu, R., Sui, W., & Zhang, M. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c07723 · Cited by 20
Wei, Q., Zhang, Q., Wu, Y., Han, S., Yin, L., Zhang, J., Gao, Y., Shen, H., Jing, Z., Chu, J., et al. (2023) · Discover Oncology · doi:10.1007/s12672-023-00612-7 · Cited by 20
Braga, A. L., de Menezes, A. P. M., Santos, J. V. D. O., dos Reis, A. C., de Lima, R. M. T., da Mata, A. M. O. F., Paz, M. F. C. J., Alves, L. B. D. S., Shaw, S., Uddin, S. J., et al. (2018) · Chemosphere · doi:10.1016/j.chemosphere.2018.04.021 · Cited by 19
Helicobacter pylori Related Diseases and Osteoporotic Fractures (Narrative Review)
Fisher, L., Fisher, A., & Smith, P. N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103253 · Cited by 18
Fabbri, C., Coluccio, C., Binda, C., Fugazza, A., Anderloni, A. A., & Tarantino, I. (2021) · Endoscopic Ultrasound · doi:10.4103/eus-d-21-00015 · Cited by 17
Role of Helicobacter pylori and Other Environmental Factors in the Development of Gastric Dysbiosis
Gomez-Ramirez, U., Valencia‐Mayoral, P., Mendoza-Elizalde, S., Murillo-Eliosa, J. R., Solórzano‐Santos, F., Contreras-Rodríguez, A., Zúñiga, G., Aguilar-Rodea, P., Jiménez-Rojas, V., Galindo, J. C. V., et al. (2021) · Pathogens · doi:10.3390/pathogens10091203 · Cited by 16
Human gastric microbiota analysis of refractory H. pylori infection
Huang, X., Zhang, D., Li, D., Lv, Y., Chen, S., & Bai, F. (2024) · Scientific Reports · doi:10.1038/s41598-024-66339-9 · Cited by 15
Eosinophils, Hypoxia-Inducible Factors, and Barrier Dysfunction in Functional Dyspepsia
Hari, S., Burns, G. L., Hoedt, E. C., Keely, S., & Talley, N. J. (2022) · Frontiers in Allergy · doi:10.3389/falgy.2022.851482 · Cited by 15
Zhang, T., Zhang, B., Ma, X., Zhang, J., Wei, Y., Wang, F., & Tang, X. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1109510 · Cited by 15
Ghuriani, V., Wassan, J. T., Tripathi, P., & Chauhan, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125590 · Cited by 14
Refractory Helicobacter pylori infection and the gastric microbiota
Liu, D., Wang, J., & Xie, Y. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.976710 · Cited by 10
Huang, Y., Kang, Z., He, Y., Qiu, Y., Song, Y., & Liu, W. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1343564 · Cited by 10
Lee, H. W., Yang, X., Jin, P.-R., Won, K., Kim, C. H., & Jeong, H. (2024) · Drug Metabolism and Disposition · doi:10.1124/dmd.123.001541 · Cited by 9
Profiling the Gastrointestinal Microbiota
Posteraro, B., Maio, F. D., & Gasbarrini, A. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1302-3_10 · Cited by 9
Self-citationExploring the Interplay: Oral–Gut Microbiome Connection and the Impact of Diet and Nutrition
Parveen, S., Alqahtani, A. S., Aljabri, M. Y., Dawood, T., Khan, S. S., Gupta, B., Vempalli, S., Hassan, A. A.-H. A.-A., & Elamin, N. M. H. (2024) · European Journal of General Dentistry · doi:10.1055/s-0044-1786154 · Cited by 11
Influence of Factors Altering Gastric Microbiota on Bariatric Surgery Metabolic Outcomes
Gutiérrez‐Repiso, C., Moreno-Indias, I., Martín-Núñez, G. M., Ho‐Plagaro, A., Ocaña-Wilhelmi, L., García, D. F., Marín, M. G., Moreno-Ruiz, F. J., García‐Fuentes, E., & Tinahones, F. J. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00535-21 · Cited by 8
Peng, C., Xu, X., Ouyang, Y., Li, Y., Lü, N., Zhu, Y., & He, C. (2024) · Helicobacter · doi:10.1111/hel.13117 · Cited by 7
Gastric microbiota and its role in gastric carcinogenesis
Jiang, X., Peng, L., Zhang, L., Li, Z., Zhou, T., Zhang, J., Li, W., You, W., Zhang, Y., & Pan, K. (2023) · Malignancy Spectrum · doi:10.1002/msp2.15 · Cited by 8
Mucosa microbiome of gastric lesions: Fungi and bacteria interactions
Wang, Z., Ren, R., & Yang, Y. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.03.004 · Cited by 7
Acevedo, A., Durán, C., Kuo, M.-J., Ciucci, S., Schroeder, M., & Cannistraci, C. V. (2022) · IEEE Access · doi:10.1109/access.2022.3152789 · Cited by 16
Self-citationSbeit, W., Kadah, A., Shahin, A., Nizar, A. B. E. D., Haddad, H., Jabbour, A. R., Ahmad, H. S., Pellicano, R., Khoury, T., & Mari, A. (2021) · Minerva Medica · doi:10.23736/s0026-4806.20.07139-6 · Cited by 6
Soliman, N. S., Soliman, M. S., Elhossary, W., & El‐Kholy, A. (2025) · BMC Microbiology · doi:10.1186/s12866-025-04095-0 · Cited by 5
Lupu, A., Răileanu, A. A., Bozomitu, L. I., Gimiga, N., Forna, L., Anton, C., Săsăran, M. O., Nedelcu, A. H., Ghica, D. C., Anton, E., et al. (2025) · Nutrients · doi:10.3390/nu17162711 · Cited by 4
The Relationship Between Functional Dyspepsia, PPI Therapy, and the Gastric Microbiome
Jagdish, B., & Kilgore, W. R. (2021) · Kansas Journal of Medicine · doi:10.17161/kjm.vol1414831 · Cited by 4
Gazi, U., Koçer, G., Ruh, E., Holyavkin, C., Tosun, Ö., Celik, M., Çört, A., & Birsen, O. (2024) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.19304 · Cited by 4
Tokunaga, K., Miyoshi, S., Hojo, F., Yonezawa, H., Ida∥, Y., Oka, K., Takahashi, M., Kamiya, S., Miyoshi, J., Hisamatsu, T., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-12211-3 · Cited by 3
Development of probiotic functional food and evaluation of its functional properties
Mondal, A., Kumar, T., Sharma, V., & Roy, S. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.104919 · Cited by 3
Duodenal Microbiome and Its Clinical Implications in Functional Dyspepsia
Kim, S. H. (2022) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2022.027 · Cited by 3
Lakshmisai, S. S., Bheemaneni, R. S., Nwachukwu, E. C., Nigam, A., Sakarkar, P., & Khan, S. (2025) · Cureus · doi:10.7759/cureus.90606 · Cited by 6
Kadi, R., Debbache-Benaida, N., Saidene, N., Chaher-Bazizi, N., Belkhir, S., Yous, F., Zaidi, S., Abbou, A., Fechter, P., & Janel‐Bintz, R. (2025) · Waste and Biomass Valorization · doi:10.1007/s12649-025-03432-8 · Cited by 2
Zhang, Z., Tao, H., Mao, K., Meng, F., Jiang, S., Chen, J. Q., He, X., & Tian, X. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.121147 · Cited by 2
The Gastric Microbiome in Benign and Malignant Diseases
Bartelli, T. F., Coelho, L. G. V., & Dias‐Neto, E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815249-2.00010-5 · Cited by 2
Place of Probiotics in Anti-Helicobacter Therapy
Plotnikova, Y. Y., & Zakharova, Y. V. (2020) · Effective Pharmacotherapy · doi:10.33978/2307-3586-2020-16-15-40-47 · Cited by 2
Acevedo, A., Ciucci, S., Kuo, M.-J., Durán, C., & Cannistraci, C. V. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1912.12418 · Cited by 2
Self-citationNonlinear Markov Clustering by Minimum Curvilinear Sparse SimilarityPreprint
Durán, C., Acevedo, A., Ciucci, S., Muscoloni, A., & Cannistraci, C. V. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1912.12211 · Cited by 2
Self-citationHoedt, E. C., Burns, G. L., Kang, S., Bruce, J. K., Morrison, M., Keely, S., & Talley, N. J. (2026) · Neurogastroenterology & Motility · doi:10.1111/nmo.70238 · Cited by 1
Gastric Microbiota Dysbiosis and Microbiome-Based Interventions in Chronic Atrophic Gastritis
Li, A., Yang, H. P., Walayat, B., Saleem, A., Zhao, J., Wang, Q., Zhang, X., Li, C. L., Liu, Y., Lu, S., et al. (2026) · Nutrients · doi:10.3390/nu18132165 · Cited by 1
Calou, I. B. F. (2024) · Seven Editora eBooks · doi:10.56238/sevened2023.006-108 · Cited by 1
The role of in the development of small intestinal bacterial overgrowth syndrome
Kolmogorova, T. O., & Anchikova, T. A. (2019) · Russian Journal of Evidence-Based Gastroenterology · doi:10.17116/dokgastro2019803112 · Cited by 1
Acid suppression and effects on the gastrointestinal microbiome
Korus, H., & Vakil, N. B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95070-1.00011-4 · Cited by 1
Ciucci, S., Durán, C., Palladini, A., Ijaz, U. Z., Sterbini, F. P., Masucci, L., Cammarota, G., Ianiro, G., Spuul, P., Schroeder, M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.24.005587 · Cited by 1
Self-citationClinical Significance of Changes in Gut Microbiome Associated with Use of Proton Pump Inhibitors
Kim, T. J., & Lee, H. (2020) · The Korean Journal of Helicobacter and Upper Gastrointestinal Research · doi:10.7704/kjhugr.2020.0014
Impact of Helicobacter Pylori Eradication Therapy on Gastric MicrobiomePreprint
Mao, L.-Q., Zhou, Y., Wang, S., Chen, L., Hu, Y., Yu, L.-M., Xu, J., & Lü, B. (2021) · Research Square · doi:10.21203/rs.3.rs-455395/v1
Gravity anomalies in Maine: Chapter 31
Kane, M. F., & Bromery, R. W. (1968)
Wang, Z., & Yunsheng, Y. (2019) · Encyclopedia of Gastroenterology · doi:10.1016/b978-0-12-801238-3.62158-x
Microbial Drug Interactions and Human Health
Ilhan, Z. E., & Herbst‐Kralovetz, M. M. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160950-00120
Additional file 1 of Impact of Helicobacter pylori eradication on the gastric microbiome
Mao, L.-Q., Zhou, Y., Wang, S., Chen, L., Hu, Y., Yu, L.-M., Xu, J., & Lü, B. (2021) · Figshare · doi:10.6084/m9.figshare.16807741
Additional file 2 of Impact of Helicobacter pylori eradication on the gastric microbiome
Mao, L.-Q., Zhou, Y., Wang, S., Chen, L., Hu, Y., Yu, L.-M., Xu, J., & Lü, B. (2021) · Figshare · doi:10.6084/m9.figshare.16807744
Metadata
- Authors
- Paroni Sterbini, F., Palladini, A., Masucci, L., Cannistraci, C. V., Pastorino, R., Ianiro, G., Bugli, F., Martini, C., Ricciardi, W., Gasbarrini, A., Sanguinetti, M., Cammarota, G., & Posteraro, B.
- Affiliations
- Institute of Microbiology, Università Cattolica del Sacro Cuore, Rome, Italy
- Università Cattolica del Sacro Cuore (IT)
- Biotechnologisches Zentrum (DE)
- ORCID
- Venue
- Applied and Environmental Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2016-11-15
- Volume
- 82
- Issue
- 22
- Pages
- 6633-6644
- ISSN
- 0099-2240 (ISSN-L)
- 1098-5336
- PMC
- PMC5086557
- OpenAlex
- W2517918142
- Cited by
- 108
- References
- 60
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 10 · 2023: 11 · 2022: 11 · 2021: 18 · 2020: 12 · 2019: 14 · 2018: 6 · 2017: 8
- FWCI
- 10.34
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Applied and Environmental Microbiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Università Cattolica del Sacro Cuore (Linea D1, Linea D3.2-2013)
- Technische Universität Dresden
- Topics
- Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- proton pump inhibitors, omeprazole, dyspepsia, gastric microbiota, Helicobacter pylori infection, Streptococcus, Streptococcaceae, Firmicutes, Helicobacter, dyspepsia treatment
- MeSH terms
- Firmicutes, Bacillota, Gastrointestinal Microbiome, Adult, Aged, Anti-Bacterial Agents, Bacteria, Dyspepsia, Female, Gastric Mucosa, Humans, Middle Aged, Omeprazole, RNA, Ribosomal, 16S, Streptococcus, Helicobacter pylori, Helicobacter Infections, Genes, rRNA, Proteobacteria, Bacteroidetes, Proton Pump Inhibitors, High-Throughput Nucleotide Sequencing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
